window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Antibody drug conjugates
  • Artificial Intelligence
  • Biologics & Biosimilars
  • Biomanufacturing
  • Biotech
  • Cardiovascular diseases
  • CDMOs & Manufacturing
  • Cell & Gene Therapy
  • Central Nervous System
  • Child & Adolescnt Health
  • Chronic diseases
  • Clinical Development
  • Clinical studies
  • Clinical Trials
  • Data Management
  • Dermatology
  • Diagnostics
  • Digital Health
  • Drug approval
  • Drug Delivery & Formulation
  • Drug Development
  • Drug discovery
  • European biotech
  • Events and Conferences
  • Facilities and infrastructure
  • FDA
  • Funding
  • Gastroenterology
  • Genetic Diseases
  • Genomics and sequencing
  • Global health
  • Healthcare leadership
  • Hematology
  • Immunology
  • Infectious Diseases
  • Ingredients
  • Liver disease
  • Logistics and distribution
  • Manufacturing
  • Market Access & Commercialization
  • Medical devices
  • Mental health
  • Mergers & Acquisitions
  • Metabolic Diseases
  • Middle East
  • Movers & Shakers
  • Neurosciences
  • Obesity
  • Oncology
  • Opthalmology
  • Orphan drugs
  • Orthapaedics
  • Packaging
  • Partnerships & Funding
  • Patient Centricity
  • Peptides
  • Pharmaceuticals and therapeutics
  • Pharmacovigilance
  • Precision medicine
  • Psychadelics
  • Rare Diseases
  • Real world evidence
  • Regulatory Affairs
  • Research & Development
  • Respiratory
  • RNA Therapeutics
  • Single Cell analysis
  • Startups and innovations
  • Supply Chain & Logistics
  • Sustainability
  • Technology and platforms
  • Uncategorised
  • Vaccines
  • Women in Pharma
  • Women's Health
  • Cardiovascular diseases,Clinical Trials,Rare Diseases,Regulatory Affairs,Research & Development

    Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program

    read more
  • Clinical Trials,Neurosciences,Partnerships & Funding,Research & Development

    City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism

    read more
  • Ingredients,Manufacturing,Packaging,Pharmaceuticals and therapeutics

    BIOGRUND and Seprify launch plant-based tablet coating to replace titanium dioxide

    read more
  • Artificial Intelligence,Biotech,Research & Development,Technology and platforms

    Nanotube injector enables controlled cytoplasmic transfer between living cells

    read more
  • Artificial Intelligence,Diagnostics,Digital Health,Medical devices,Women's Health

    Diagnoly launches Fetoly on iOS for real-time fetal ultrasound AI

    read more
  • Diagnostics,Drug discovery,Manufacturing,Research & Development,Technology and platforms

    Thermo Fisher launches Glacios 3 cryo-TEM to expand access to structural biology imaging

    read more
  • Clinical Development,Clinical Trials,Rare Diseases,Research & Development,Technology and platforms

    PRISM ALS initiative develops patient-derived stem cell models to improve ALS/MND drug discovery

    read more
  • Biotech,Drug discovery,Healthcare leadership,Movers & Shakers,Research & Development,Startups and innovations,Technology and platforms

    Proxygen appoints Chiara Conti as chief scientific officer to support move into clinical-stage development

    read more
  • Clinical Development,Clinical Trials,Rare Diseases,Research & Development

    Efzimfotase alfa shows mixed Phase 3 results in hypophosphatasia across pediatric and adult patients

    read more
  • CDMOs & Manufacturing,Cell & Gene Therapy,Immunology,Oncology,Pharmaceuticals and therapeutics,Rare Diseases,Research & Development

    ImmuneOncia Therapeutics and Lonza agree manufacturing partnership for PD-L1 antibody Danburstotug

    read more
  • CDMOs & Manufacturing,Manufacturing,Market Access & Commercialization,Pharmaceuticals and therapeutics

    Vetter recognised as 2026 CDMO Leadership Awards winner in finished dose category

    read more
  • Cell & Gene Therapy,Hematology,Manufacturing,Partnerships & Funding,Rare Diseases,Research & Development,Technology and platforms

    UMass Chan, Caring Cross and Trenchant BioSystems form sickle cell gene therapy manufacturing alliance

    read more
  • Clinical Development,Drug Development,FDA,Genetic Diseases,Orphan drugs,Pharmaceuticals and therapeutics,Rare Diseases

    BridgeBio submits FDA NDA for BBP-418 in limb-girdle muscular dystrophy type 2I/R9

    read more
  • Drug discovery,Oncology,Partnerships & Funding,Research & Development,Startups and innovations,Technology and platforms

    Symeres and Ambagon partner on molecular glue research in colorectal cancer

    read more
  • Artificial Intelligence,Drug discovery,Partnerships & Funding

    Insilico Medicine signs $2.75bn AI drug discovery deal with Eli Lilly

    read more
  • Cardiovascular diseases,Clinical Trials,Drug approval,Rare Diseases

    Chiesi gains CHMP backing for lomitapide in children with rare cholesterol disorder

    read more
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • William Blair highlights Carterra as key player in AI-driven drug discovery shift
    Categories: Artificial Intelligence, Drug Development, Drug discovery, Research & Development, Technology and platforms
  • 23andMe study links genetics to GLP-1 weight loss outcomes and side effects
    Categories: Artificial Intelligence, Clinical Development, Genomics and sequencing, Obesity, Precision medicine, Technology and platforms
  • Life Biosciences raises $80M to advance gene therapy for optic neuropathies
    Categories: Clinical Trials, Funding, Opthalmology, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top